Using Single-Cell Detection Technology to Explore Biomarkers of the Efficacy of TACE combined with Tislelizumab in the Treatment of Hepatocellular carcinoma:A Prospective Clinical Trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 440f5956e901a05d6eabe5b18f78410d4e0b6282
First added on: Apr 08, 2025